Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-045513
Filing Date
2022-02-17
Accepted
2022-02-17 16:39:38
Documents
6
Effectiveness Date
2022-02-17

Document Format Files

Seq Description Document Type Size
1 S-8 d295143ds8.htm S-8 33649
2 EX-5.1 d295143dex51.htm EX-5.1 6181
3 EX-23.1 d295143dex231.htm EX-23.1 1268
4 EX-99.1 d295143dex991.htm EX-99.1 134411
5 EX-FILING FEES d295143dexfilingfees.htm EX-FILING FEES 14506
6 GRAPHIC g295143g0217110335713.jpg GRAPHIC 2405
  Complete submission text file 0001193125-22-045513.txt   194449
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262824 | Film No.: 22648755
SIC: 2834 Pharmaceutical Preparations